title: Site-specific immunosuppression: mechanisms of cellular immunosuppression that are operative at local and systemic levels.
abstract: The cellular mechanisms by which topical cyclosporine A (tCsA) induces site-specific immunosuppression were investigated. Experiments were designed to elucidate how cyclosporine A (CsA) suppresses activated immunocytes in animals that are undergoing local alloactivation and concomitant tCsA immune suppression. Lewis rats received dual Lewis x Brown Norway rat skin allografts; the rats were treated with systemic CsA (sCsA) at 8 mg/kg/day for 10 days after grafting and then tCsA and vehicle thereafter. CsA added to mixed lymphocyte reactions 24 hours after culture initiation modeled the local effects of CsA on alloactivated immunocytes, and tCsA in conjunction with limited sCsA prolonged local skin allograft survival. CsA inhibited both antigen-specific and nonspecific activated alloresponses of immunocytes from animals that had received allografts and that underwent limited sCsA treatment only in a dose-dependent manner. When tCsA had been applied, immunocyte responses to a nonspecific antigen were extremely CsA-resistant as compared with those induced by antigen-specific suppression. However, this nonspecific alloresponse was fully suppressible with the use of elevated CsA doses (66 microg/mL); thus alloresponding immunocytes were significantly more sensitive to CsA if they were challenged with the donor antigen and preexposed to limited sCsA followed by tCsA in vivo.
authors.affiliation: Department of Surgery, College of Medicine, University of California-Irvine, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Patam
authors.forename: H S
authors.initials: HS
authors.lastname: Tran
authors.forename: R
authors.initials: R
authors.lastname: Llull
authors.forename: F A
authors.initials: FA
authors.lastname: Chrzanowski
authors.forename: K S
authors.initials: KS
authors.lastname: Black
authors.forename: C W
authors.initials: CW
authors.lastname: Hewitt
mesh_terms: D000287:Administration, Topical; D000818:Animals; D016525:Antigenic Modulation; D002056:Burns / Q000276:immunology / Q000628:therapy; D016572:Cyclosporine / Q000276:immunology / Q000494:pharmacology*; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000276:immunology / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D016038:Skin Transplantation
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine